Cabot Corp.
CBT | NYSE
$76.17
+$1.74 (+2.34%)
Nov 2, 2026, 12:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.71B | 3.99B | 3.93B | 4.32B | 3.41B | 2.61B |
Cost of Revenue | 2.77B | 3.03B | 3.09B | 3.44B | 2.61B | 2.11B |
Gross Profit | 940M | 960M | 839M | 885M | 799M | 500M |
Operating Income | 621M | 614M | 526M | 389M | 454M | 21M |
Interest Income | 27M | 32M | 31M | 11M | 8M | 8M |
Pretax Income | 572M | 535M | 456M | 345M | 409M | -30M |
Net Income | 331M | 380M | 445M | 209M | 250M | -238M |
Selling & General & Admin | 260M | 283M | 253M | 258M | 289M | 292M |
Research & Development | 59M | 63M | 57M | 55M | 56M | 57M |
Other Expenses | n/a | n/a | 3M | 183M | n/a | 130M |
Operating Expenses | 319M | 346M | 313M | 496M | 345M | 479M |
Interest Expense | 76M | 81M | 90M | 56M | 49M | 53M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.09B | 3.38B | 3.41B | 3.93B | 2.96B | 2.59B |
Income Tax Expense | 196M | 111M | -28M | 102M | 123M | 191M |
Shares Outstanding (Basic) | 53.7M | 54.3M | 55.24M | 56.25M | 56.73M | 56.53M |
Shares Outstanding (Diluted) | 54.2M | 55.7M | 56.5M | 56.9M | 56.8M | 56.6M |
EPS (Basic) | 6.07 | 6.79 | 7.79 | 3.65 | 4.36 | -3.96 |
EPS (Diluted) | 6.02 | 6.72 | 7.73 | 3.62 | 4.34 | -3.96 |
EBITDA | 794M | 761M | 685M | 537M | 615M | 178M |
EBIT | 640M | 610M | 541M | 391M | 455M | 20M |
Depreciation & Amortization | 154M | 151M | 144M | 146M | 160M | 158M |
Add to Watchlist
Select watchlists to add or remove CBT